Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add‐on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA‐PRIME)

AIM: To compare (in the LIRA‐PRIME [NCT02730377], a randomized open‐label trial), the efficacy of liraglutide in controlling glycaemia versus an oral antidiabetic drug (OAD) in patients with uncontrolled type 2 diabetes (T2D), despite metformin use in a primary care setting (n = 219 sites, n = 9 cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Unger, Jeff, Allison, Dale C., Kaltoft, Margit, Lakkole, Kavitha, Panda, Jayant K., Ramesh, Chethana, Sargin, Mehmet, Smolyarchuk, Elena, Twine, Melissa, Wolthers, Benjamin, Yarimbas, Gizem, Zoghbi, Marouan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298244/
https://www.ncbi.nlm.nih.gov/pubmed/34622567
http://dx.doi.org/10.1111/dom.14566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298244/
https://www.ncbi.nlm.nih.gov/pubmed/34622567
http://dx.doi.org/10.1111/dom.14566

Ejemplares similares